AIC
CELG

Ameritas Investment Company’s Celgene Corp CELG Stock Holding History

Ameritas Investment Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,244
Closed -$127K – 1725
2019
Q3 		$127K Buy
+1,244
New +$118K 0.03% 426
2019
Q2 		– Sell
-3,904
Closed -$368K – 995
2019
Q1 		$368K Buy
+3,904
New +$341K 0.07% 219

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Ameritas Investment Company's CELG Position: Q4 2019 in Review

Ameritas Investment Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,244 shares — an estimated $127K sold.

Ameritas Investment Company first reported a position in CELG in Q1 2019 and held it in 2 quarters. The position peaked at $368K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ameritas Investment Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 1,244 Celgene Corp shares in Q4 2019, an estimated $127K.
  • Ameritas Investment Company first reported a position in Celgene Corp in Q1 2019 and held it in 2 quarters.
  • Ameritas Investment Company's Celgene Corp position peaked at $368K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ameritas Investment Company's 13F filing for Q4 2019, filed 18 Feb 2020.